AG
WVE icon

Ascent Group’s Wave Life Sciences WVE Stock Holding History

Ascent Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.1K Buy
+10,342
New +$68.6K ﹤0.01% 804
2025
Q2 		– Sell
-10,237
Closed -$82.7K – 774
2025
Q1 		$82.7K Buy
+10,237
New +$112K ﹤0.01% 688

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Ascent Group's WVE Position: Q2 2026 in Review

Ascent Group opened a new position in Wave Life Sciences (WVE) in Q2 2026: 10,342 shares worth $60.1K. The stake represents ﹤0.01% of the portfolio and ranks #804 among its holdings. This is a return to the name: Ascent Group previously reported a position in WVE as recently as Q1 2025.

Ascent Group first reported a position in WVE in Q1 2025 and has held it in 2 quarters since. The position peaked at $82.7K in Q1 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Ascent Group held 10,342 shares of Wave Life Sciences worth $60.1K as of Q2 2026.
  • Wave Life Sciences was a new Ascent Group position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Ascent Group's portfolio in Q2 2026, its #804 holding.
  • Ascent Group first reported a position in Wave Life Sciences in Q1 2025 and has held it in 2 quarters since.
  • Ascent Group's Wave Life Sciences position peaked at $82.7K in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.